Headlands Research

We are in a new, exciting era of pharmacological weight management that has the potential to positively impact the lives of a large part of our population. Read this blog by Ryan Cady, our Director of Endocrine/Metabolic/Pain Strategy, to learn about some of the weight management trials that Headlands Research has supported, including for glucagon-like peptide 1 (GLP-1) receptor agonists (RAs), and how, for the first time since 1999, we are seeing a decrease in the rate of obesity in the United States. #GLP1 #ObesityCare #ClinicalTrialSites https://lnkd.in/erpfwZ-Z

Mental health disorders continue to be a major public health concern, and treatment resistance affects 20% to 60% of these individuals. Read our blog post to learn more about three mental health conditions for which treatment resistance is common: depression, obsessive-compulsive disorder (OCD), and post-traumatic stress disorder (PTSD). #HeadlandsResearch  #MentalHealth #ClinicalTrials https://lnkd.in/gCY3qSFx

As a result of vaccination initiatives, diseases such as smallpox have been eradicated. However, continued vigilance and ongoing vaccine development are needed for the betterment of public health. Read this blog post from Michelle Sowell, Director of Vaccine Strategy, for an overview of several vaccine initiatives in the United States. #Vaccination #PublicHealth #InfectiousDiseases https://lnkd.in/eNbfvXr3

Although it's essential to get new Alzheimer's disease (AD) treatments to the people who need them, drug development for AD is often considered too risky and lengthy. Read this white paper to learn about ways for AD clinical trials to overcome slow recruitment, improve enrollment and retention, and reach a representative sample of people with AD. #ClinicalTrials #AlzheimersClinicalTrials #AlzheimersResearch #HeadlandsResearch https://lnkd.in/eZhuyu5f

Vaccination is considered one of the most cost-effective methods to avoid disease and the associated morbidity and mortality, preventing 2-3 million deaths a year globally. Despite this, only 48.5% of adults and 53.9% of children were vaccinated against influenza in the 2023-2024 season in the US. Download this white paper to learn about strategies we can use to improve participation in flu vaccination trials, ensure equitable access to the studies, and overcome other common vaccine research challenges. #FluSeason #FluShot #Vaccination #HeadlandsResearch https://lnkd.in/ez2rjDj2

A flu vaccine can take flu from wild to mild. Get your flu shot during National Influenza Vaccination Week and help protect yourself and others from the negative impacts of the virus. #NIVW #NationalInfluenzaVaccinationWeek #FluShot #FluVaccine

Wishing you and yours a Happy Thanksgiving from the Headlands Research family! May your holiday be filled with good food, warm conversations, and gratitude. #Thanksgiving

What makes working at Headlands Research so rewarding? According to Dr. Siddharth Kaul, Investigator at Clinical Research Professionals (CRP), a Headlands Research site, it's all about being a part of cutting-edge research. Learn more about Dr. Kaul's work at CRP, and the family approach that the team at CRP takes for our participants in this video. #HeadlandsResearch #ClinicalTrialSites #ClinicalTrials https://lnkd.in/e67TNnJh

We are in a new, exciting era of pharmacological weight management that has the potential to positively impact the lives of a large part of our population. Read this blog by Ryan Cady, our Director of Endocrine/Metabolic/Pain Strategy, to learn about some of the weight management trials that Headlands Research has supported, including for glucagon-like peptide 1 (GLP-1) receptor agonists (RAs), and how, for the first time since 1999, we are seeing a decrease in the rate of obesity in the United States. #GLP1 #ObesityCare #ClinicalTrialSites https://lnkd.in/erpfwZ-Z

This November we are answering the call from the Alzheimer's Foundation of America to raise awareness for Alzheimer's disease, a condition that impacts more than 6.2 million Americans and their loved ones. Join us during Alzheimer's Awareness Month as we show support for those living with the disease! #AlzFdn #AlzheimersAwarenessMonth #AlzResearch